Orion upgrades 2012 profit outlook

A positive profit warning from Finnish pharmaceutical company Orion (OMXH: ORNBV) helped its stock record a nice 6% gain on Tuesday. The company raises both full-year net sales and operating profit outlook from ”similar” to ”slightly higher” compared to last year. Capital expenditures guidance of 50 million Euros excluding substantial acquisitions is maintained. The closing price 16.34 Euros is the highest for quite some time for the more liquid b-share as investors for once pushed back concerns of upcoming patent expirations.